Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MYO
SellHot AirMyomo, Inc. · Healthcare · United States · $63M · Avg Vol: $916K/d
COMPANY DESCRIPTION
Myomo, Inc. is a medical robotics company that develops and markets wearable orthotic devices for individuals with neuromuscular conditions. The company is a niche leader in the non-invasive robotic bracing market, providing proprietary myoelectric technology to restore movement in paralyzed or weakened upper limbs.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.6M | 19.2M | 32.6M | 40.9M | 38.1% | 43.3M | 45.6M | 51.2M | 11.9% |
| EPS | -0.30 | -0.28 | -0.16 | -0.37 | — | -0.34 | -0.31 | -0.22 | — |
| Shares | 39.6M | 27.1M | 34.4M | 38.5M | -2.9% | 39.6M | — | — | — |
| Debt | 0.6M | 0.6M | 8.1M | 19.4M | 227.1% | 20.1M | — | — | — |
| Equity | 6.4M | 9.0M | 24.7M | 11.4M | 21.5% | — | — | — | — |
| Op CF | -10.2M | -6.2M | -3.3M | -14.5M | — | -7.1M | — | — | — |
| Inv CF | -0.3M | -2.0M | 0.3M | -7.1M | — | — | — | — | — |
| Fin CF | 0.4M | 9.7M | 20.9M | 11.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MYO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MYO | Myomo, Inc.(you) | $63M | 34 | Sell |
| ECOR | electroCore, Inc. | $87M | 32 | Sell |
| OM | Outset Medical, Inc. | $74M | 24 | Sell |
| SRTS | Sensus Healthcare, Inc. | $58M | 22 | Sell |
| XTNT | Xtant Medical Holdings, Inc. | $54M | 44 | Hold |
| LUNG | Pulmonx Corporation | $102M | 29 | Sell |
| MXCT | MaxCyte, Inc. | $126M | 32 | Sell |
| SNWV | SANUWAVE Health, Inc. | $51M | 47 | Hold |
| ARAY | Accuray Incorporated | $53M | 19 | Strong Sell |
| LNSR | LENSAR, Inc. | $102M | 22 | Sell |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%